| Literature DB >> 29186040 |
Jae-Wook Shin1, Kyeong-Jun Kim2, Jinho Yoon3, Jinhee Jo4, Waleed Ahmed El-Said5,6, Jeong-Woo Choi7,8.
Abstract
Several neurological disorders such as Alzheimer's disease and Parkinson's disease have become a serious impediment to aging people nowadays. One of the efficient methods used to monitor these neurological disorders is the detection of neurotransmitters such as dopamine. Metal materials, such as gold and platinum, are widely used in this electrochemical detection method; however, low sensitivity and linearity at low dopamine concentrations limit the use of these materials. To overcome these limitations, a silver nanoparticle (SNP) modified electrode covered by graphene oxide for the detection of dopamine was newly developed in this study. For the first time, the surface of an indium tin oxide (ITO) electrode was modified using SNPs and graphene oxide sequentially through the electrochemical deposition method. The developed biosensor provided electrochemical signal enhancement at low dopamine concentrations in comparison with previous biosensors. Therefore, our newly developed SNP modified electrode covered by graphene oxide can be used to monitor neurological diseases through electrochemical signal enhancement at low dopamine concentrations.Entities:
Keywords: dopamine; electrochemical signal; graphene oxide; neurotransmitter; silver nanoparticle
Mesh:
Substances:
Year: 2017 PMID: 29186040 PMCID: PMC5750767 DOI: 10.3390/s17122771
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Schematic diagram of an SNP modified electrode covered by graphene oxide and the process of dopamine detection.
Figure 2SEM images of the (a) ITO electrode, (b) ITO electrode covered by graphene oxide, (c) SNP modified electrode, (d) magnification of the SNP modified electrode, (e) SNP modified electrode covered by graphene oxide and (f) magnification of the SNP modified electrode covered by graphene oxide; (g) Raman spectroscopy of the ITO electrode, ITO electrode covered by graphene oxide and SNP modified electrode covered by graphene oxide.
Figure 3Electrochemical signal enhancement of the ITO electrode, SNP modified electrode, ITO electrode covered by graphene oxide and SNP modified electrode covered by graphene oxide with the addition of a 50 μM dopamine solution using (a) CV measurements and (b) comparison of the absolute Ipa values.
Figure 4(a) Amperometric i-t dopamine response with the addition of various dopamine concentrations; (b) linear curve of the peak current values and different dopamine concentrations (n = 3).
Comparison of some electrochemical characteristics of different graphene-based or SNP-based electrodes for the detection of dopamine.
| Electrode | Methods | Linear Range (μM) | Detection Limit (μM) | Reference |
|---|---|---|---|---|
| pGO 1-GNP 2-pGO | CV, AM 9 | 0.1–30 | 1.28 | [ |
| Pdop 3@Gr 4/MWCNTs 5 | DPV | 7–297 | 1.0 | [ |
| Ag-CNT 6/CPE 7 | DPV | 0.8–64 | 0.3 | [ |
| SNP/GO 8 | CV, AM | 0.1–100 | 0.2 | This work |
1 Porous graphene oxide; 2 Gold nanoparticle; 3 Polydopamine; 4 Graphene; 5 Multi-walled carbon nanotubes; 6 Carbon nanotube; 7 Carbon-paste electrode; 8 Graphene oxide; 9 Amperometry.
Figure 5(a) Amperometric i-t measurement with the continuous addition of 10 μM of each of dopamine, uric acid and ascorbic acid; (b) DPV for the concentration of dopamine ranging from 10 μM to 100 μM in the presence of 50 μM of both uric acid and ascorbic acid.